Proceedings of the National Academy of Sciences · 29 September 2026 · From issue 44
The PKMYT1-ALDOA axis drives chemoresistance in cholangiocarcinoma by enhancing glycolysis and MRE11 lactylation
In mice, blocking one protein made resistant bile duct cancer respond to chemotherapy again.
Wei Wu, Jian Wang et al.
A hard-to-treat bile duct cancer uses one protein to fix its own broken DNA and dodge chemotherapy. That protein boosts sugar processing in cancer cells, which builds up a chemical that strengthens a DNA repair helper. Blocking the protein with a drug called RP6306 broke this process. In mice and in tumor samples from patients, the block made chemotherapy work much better.
Integrity screen: passed (3 checks) Checked 30 September 2026. Read the source
The plain-language reading of this paper is in the full issue, for subscribers.
Read the full issue